glp-1 receptor agonist use and risk of suicide death Postmarket safety profile suicide/self-injury for agonist: a real-world pharmacovigilance analysis | European Psychiatry GLP-1 Agonists in Cardiovascular Diseases:
Description
Safety Considerations : Common side effects include nausea and gastrointestinal issues, but these often improve with gradual dosage adjustments
Obviously that chart is small sample size, but CMG and MCD have traded roughly inline with (or a bit better) than the market over the past year
BYDUREON frequently asked questions
Rare Risks: Though uncommon, serious complications such as gallbladder issues or pancreatitis can occur
